Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

Depression has been tied to a two-fold increased risk offor epilepsy and a suboptimal response to initial therapy, underscoring the need for closer monitoring and integrated care.

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive disorder (MDD).

While these types of depression are similar, they may have different causes and require different treatments. Depression is one of the most common mental health conditions, affecting tens of millions ...

Over-the-counter (OTC) products like St John’s Wort and omega-3s have long been touted for helping with depression, but new research reveals that 64 different OTC products have been tested in clinical ...

Blood tests also showed a 52% drop in leptin, a hormone linked to both appetite and mood, and a 32% rise in brain-derived ...